|
Seminar luncheon
Developing Relevant Human Neural In Vitro Assays for CNS Safety Assessment and Drug Discovery: Challenges and Perspectives
Speakers:
Jonathan Davila PhD., CEO / Co-Founder, NeuCyte Inc.
Organizers:
Date:
2017-07-28
Time:
11:00-13:30 Pacific Time
Registration fee:
(USD): Food: $0.
Location:
SF Bay Area: Foster City Crowne Plaza
Major Sponsor:
Vendor show vendors registered to date:
(5)Agilent; BioLegend; Cyprotex; JL Powers & Co; Thermo Fisher Scientific, SID
Registration: http://www.PBSS.org
Registration deadline:2017-07-26
(it will close sooner if the seating cap is reached)
About the Topic
High attrition rates of novel CNS drugs indicate that current preclinical testing is largely insufficient to support development of urgently needed therapies for millions of patients. iPSC technology and rapidly improving methods to generate functional human tissues offer new opportunities to develop novel disease relevant cell-based assays. This approach comes with high expectations but also presents many challenges. NeuCyte develops human neural in vitro platforms uniquely suited for assessing relevant complex electrophysiology readouts allowing for more reliable prediction of drug efficacy, CNS safety, and identification of neurotoxicity. In this presentation, we will provide an overview of critical considerations that need to be taken when developing human iPSC derived neural in vitro assays.
2021-02-16, [Free Online Symposium] Oxbryta® (Voxelotor) tablets for Sickle Cell Disease: The R&D Journey and Lessons Learned (jointly by PBSS and CLSA)
|
2021-03-09, [Free Online Workshop] Metabolite Identification: Strategies, Techniques and Case Studies
|
2021-03-23, [Free Online Symposium] Cardiac Safety from Preclinical to the Clinic: Industry and Regulatory Trends in T-QT and Concentration-QT Studies for Assessing QT Prolongation Risks
|
2021-04-26, [Free Online Symposium] Highlights from 2020's FDA New Drug Approvals (jointly by PBSS and CLSA)
|
2021-07-29, [Free Online Symposium] Development of Inhalation Therapeutics (jointly by AAPS-BADG / PBSS / Genentech)
|
|
Ads (in random order)
Submit a Text Ad ($250 for 2 months)
Hypha Discovery Limited
Experts in drug metabolite synthesis & purification including CYP, AOX, FMO metabolites as well as O-, N-, acyl- glucuronides, glycosides & sulfates.
|
Alturas Analytics, Inc.
Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
|
MaxCyte, Inc
High transfection efficiency, cell viability, scale to e10 cells - closed system. R&D thru commercial manuf. for your cell therapy & biologics needs.
|
Gator Bio
Gator Bio Next Gen BLI: Label-free system for quantitation, kinetics, and epitope binning. Small molecules, antibodies, biomolecules, receptors.
|
BioPharmEquip
Isolators, PCM-based Smart Temp-Controlled Packaging, Viable Air Sampler, -80C Biorepository Walk-Ins, Stability Chambers, Single-Use Containment
|
Eurofins Discovery On-Demand
Take a coffee break with Discovery On-Demand! Mini webinars for remote learning avail 24/7 to accelerate your drug discovery program with confidence.
|
Eurofins Discovery Biomarker Services
Cytokine Storm Assay for immunosafety profiles, STING Assay for in-depth evaluation of immune impacts; 360+ multiparameter flow cytometry capabilities
|
|
Submit a Text Ad
|